[1] 王拥军，李子孝，谷鸿秋，等. 中国卒中报告2019（中

文版）（3）[J]. 中国卒中杂志，2020，15（12）：1251-

1263.

[2] WANG Y J，LI Z X，GU H Q，et al. China stroke

statistics 2019：a report from the National Center

for Healthcare Quality Management in Neurological

Diseases，China National Clinical Research Center

for Neurological Diseases，the Chinese Stroke

Association，National Center for Chronic and Noncommunicable

Disease Control and Prevention，

Chinese Center for Disease Control and Prevention

and Institute for Global Neuroscience and Stroke

Collaborations[J]. Stroke Vasc Neurol，2020，5（3）：

211-239.

[3] GBD 2016 Causes of Death Collaborators. Global，

regional，and national age-sex specific mortality

for 264 causes of death，1980-2016：a systematic

analysis for the Global Burden of Disease Study

2016[J]. Lancet，2017，390（10100）：1151-1210.

[4] MIJAJLOVI? M D，PAVLOVI? A，BRAININ

M，et al. Post-stroke dementia - a comprehensive

review[J]. BMC Med，2017，15（1）：11.

[5] 中国卒中学会，卒中后认知障碍管理专家委员会. 卒

中后认知障碍管理专家共识[J]. 中国卒中杂志，2017，

12（6）：519-531.

[6] 中国医师协会神经内科分会认知障碍专业委员会，

《中国血管性认知障碍诊治指南》编写组. 2019年中

国血管性认知障碍诊治指南[J]. 中华医学杂志，2019，

99（35）：2737-2744.

[7] 中国卒中学会，卒中后认知障碍管理专家委员会，徐

俊. 卒中后认知障碍患者门诊管理规范[J]. 中国卒中

杂志，2019，14（9）：909-922.

[8] 中国卒中学会卒中后认知障碍研究圆桌会议专家组.

中国卒中后认知障碍防治研究专家共识[J]. 中国卒中

杂志，2020，15（2）：158-166.

[9] MOK V C，LAM B Y，WONG A，et al. Early-onset

and delayed-onset poststroke dementia - revisiting

the mechanisms[J]. Nat Rev Neurol，2017，13（3）：

148-159.

[10] SKROBOT O A，O'BRIEN J，BLACK S，et al.

The vascular impairment of cognition classification

consensus study[J]. Alzheimers Dement，2017，13

（6）：624-633.

[11] LO J W，CRAWFORD J D，DESMOND D W，

et al. Profile of and risk factors for poststroke

cognitive impairment in diverse ethnoregional

groups[J/OL]. Neurology，2019，93（24）：

e2257-e2271[2020-02-15]. https：//doi.org/10.1212/

WNL.0000000000008612.

[12] DOUIRI A，RUDD A G，WOLFE C D. Prevalence

of poststroke cognitive impairment：South London

Stroke Register 1995-2010[J/OL]. Stroke，2013，44

（1）：138-145[2020-02-15]. https：//doi.org/10.1161/

STROKEAHA.112.670844.

[13] MUNTHE-KAAS R，AAM S，IHLE-HANSEN

H，et al. Impact of different methods defining poststroke

neurocognitive disorder：the Nor-COAST

study[J/OL]. Alzheimers Dement（NY），2020，6

（1）：e12000[2020-02-15]. https：//doi.org/10.1002/

trc2.12000.

[14] ROHDE D，GAYNOR E，LARGE M，et al. The

impact of cognitive impairment on poststroke

outcomes：a 5-year follow-up[J]. J Geriatr Psychiatry

Neurol，2019，32（5）：275-281.

[15] DING M Y，XU Y，WANG Y Z，et al. Predictors

of cognitive impairment after stroke：a prospective

stroke cohort study[J]. J Alzheimers Dis，2019，71

（4）：1139-1151.

[16] PENDLEBURY S T，ROTHWELL P M. Prevalence，

incidence，and factors associated with pre-stroke and post-stroke dementia：a systematic review and metaanalysis[

J]. Lancet Neurol，2009，8（11）：1006-1018.

[17] SURAWAN J，AREEMIT S，TIAMKAO S，et al.

Risk factors associated with post-stroke dementia：a

systematic review and meta-analysis[J]. Neurol Int，

2017，9（3）：7216.

[18] LEI C Y，DENG Q H，LI H J，et al. Association

between silent brain infarcts and cognitive function：

a systematic review and meta-analysis[J]. J Stroke

Cerebrovasc Dis，2019，28（9）：2376-2387.

[19] ZHAO L，BIESBROEK J M，SHI L，et al. Strategic

infarct location for post-stroke cognitive impairment：

a multivariate lesion-symptom mapping study[J]. J

Cereb Blood Flow Metab，2018，38（8）：1299-1311.

[20] PUY L，BARBAY M，ROUSSEL M，et al.

Neuroimaging determinants of poststroke cognitive

performance[J]. Stroke，2018，49（11）：2666-2673.

[21] LI C H，CHANG Y H，CHOU M C，et al. Factors of

post-stroke dementia：a nationwide cohort study in

Taiwan[J]. Geriatr Gerontol Int，2019，19（8）：815-

822.

[22] QUINN T J，ELLIOTT E，LANGHORNE P.

Cognitive and mood assessment tools for use in

stroke[J]. Stroke，2018，49（2）：483-490.

[23] MCGOVERN A，PENDLEBURY S T，MISHRA

N K，et al. Test accuracy of informant-based

cognitive screening tests for diagnosis of dementia

and multidomain cognitive impairment in stroke[J].

Stroke，2016，47（2）：329-335.

[24] DONNELLAN C，WERRING D. Cognitive

impairment before and after intracerebral

haemorrhage：a systematic review[J]. Neurol Sci，

2020，41（3）：509-527.

[25] MCCARTEN J R，ANDERSON P，KUSKOWSKI

M A，et al. Screening for cognitive impairment in an

elderly veteran population：acceptability and results

using different versions of the Mini-Cog[J]. J Am

Geriatr Soc，2011，59（2）：309-313.

[26] 王少石，周新雨，朱春燕. 卒中后抑郁临床实践的中

国专家共识[J]. 中国卒中杂志，2016，11（8）：685-

693.

[27] KATZMAN R，ZHANG M Y，OUANG YA Q，et

al. A Chinese version of the Mini-Mental State

Examination; impact of illiteracy in a Shanghai

dementia survey[J]. J Clin Epidemiol，1988，41（10）：

971-978.

[28] LEES R A，HENDRY BA K，BROOMFIELD N，et

al. Cognitive assessment in stroke：feasibility and

test properties using differing approaches to scoring

of incomplete items[J]. Int J Geriatr Psychiatry，2017，

32（10）：1072-1078.

[29] KALBE E，REINHOLD N，BRAND M，et al. A

new test battery to assess aphasic disturbances

and associated cognitive dysfunctions -- German

normative data on the aphasia check list[J]. J Clin

Exp Neuropsychol，2005，27（7）：779-794.

[30] 王荫华. 汉语失语症失语类型的鉴别诊断流程（一）

[J]. 中国康复理论与实践，1997，3（1）：10-12.

[31] 王荫华. 汉语失语症失语类型的鉴别诊断流程（二）

[J]. 中国康复理论与实践，1997，3（2）：57-59.

[32] 恽晓平，郭华珍，陈巍. 洛文斯顿作业疗法用认知

评定成套测验的应用研究[J]. 中国康复理论与实践，

1999，5（3）：16-19，26.

[33] WINSTEIN C J，STEIN J，ARENA R，et al.

Guidelines for adult stroke rehabilitation and

recovery：a guideline for healthcare professionals

from the American Heart Association/American

Stroke Association[J/OL]. Stroke，2016，47（6）：

e98-e169[2020-02-15]. https：//doi.org/10.1161/

STR.0000000000000098.

[34] SALVADORI E，PASI M，POGGESI A，et al.

Predictive value of MoCA in the acute phase of

stroke on the diagnosis of mid-term cognitive

impairment[J]. J Neurol，2013，260（9）：2220-2227.

[35] LIM J S，OH M S，LEE J H，et al. Prediction of

post-stroke dementia using NINDS-CSN 5-minute

neuropsychology protocol in acute stroke[J]. Int

Psychogeriatr，2017，29（5）：777-784.

[36] DONG Y H，XU J，CHAN B P，et al. The Montreal

Cognitive Assessment is superior to National

Institute of Neurological Disease and Stroke-

Canadian Stroke Network 5-minute protocol in

predicting vascular cognitive impairment at 1 year[J/

OL]. BMC Neurol，2016，16：46[2020-02-15].

https：//doi.org/10.1186/s12883-016-0570-y.

[37] KANDIAH N，CHANDER R J，LIN X，et

al. Cognitive impairment after mild stroke：

development and validation of the SIGNAL2 risk

score[J]. J Alzheimers Dis，2016，49（4）：1169-1177.

[38] CHANDER R J，LAM B Y K，LIN X，et

al. Development and validation of a risk score

（CHANGE）for cognitive impairment after ischemic

stroke[J]. Sci Rep，2017，7（1）：12441.

[39] WASHIDA K，KOWA H，HAMAGUCHI H，et al.

Validation of the R2CHADS2 and CHADS2 scores

for predicting post-stroke cognitive impairment[J].

Intern Med，2017，56（20）：2719-2725.

[40] HE M L，WANG J E，LIU N，et al. Effects of

blood pressure in the early phase of ischemic

stroke and stroke subtype on poststroke cognitive

impairment[J]. Stroke，2018，49（7）：1610-1617.

[41] CASOLLA B，CAPARROS F，CORDONNIER C，et al. Biological and imaging predictors of cognitive

impairment after stroke：a systematic review[J]. J

Neurol，2019，266（11）：2593-2604.

[42] DE BRUIJN R F，BOS M J，PORTEGIES M

L，et al. The potential for prevention of dementia

across two decades：the prospective，populationbased

Rotterdam study[J/OL]. BMC Med，2015，13：

132[2020-02-15]. https：//doi.org/10.1186/s12916-015-

0377-5.

[43] NORTON S，MATTHEWS F E，BARNES D E，et

al. Potential for primary prevention of Alzheimer's

disease：an analysis of population-based data[J].

Lancet Neurol，2014，13（8）：788-794.

[44] YU J T，XU W，TAN C C，et al. Evidence-based

prevention of Alzheimer's disease：systematic review

and meta-analysis of 243 observational prospective

studies and 153 randomised controlled trials[J]. J

Neurol Neurosurg Psychiatry，2020，91（11）：1201-

1209.

[45] KUZMA E，LOURIDA I，MOORE S F，et al.

Stroke and dementia risk：a systematic review and

meta-analysis[J]. Alzheimers Dement，2018，14（11）：

1416-1426.

[46] 中华医学会神经病学分会，中华医学会神经病学分

会脑血管病学组. 中国急性缺血性脑卒中诊治指南

2018[J]. 中华神经科杂志，2018，51（9）：666-682.

[47] ROSENBAUM HALEVI D，BURSAW A W，

KARAMCHANDANI R R，et al. Cognitive deficits

in acute mild ischemic stroke and TIA and effects of

rt-PA[J]. Ann Clin Transl Neurol，2019，6（3）：466-

474.

[48] BROOME L J，BATTLE C E，LAWRENCE M，et

al. Cognitive outcomes following thrombolysis in

acute ischemic stroke：a systematic review[J]. J

Stroke Cerebrovasc Dis，2016，25（12）：2868-2875.

[49] NYS G M，VAN ZANDVOORT M J，ALGRA

A，et al. Cognitive and functional outcome after

intravenous recombinant tissue plasminogen

activator treatment in patients with a first

symptomatic brain infarct[J]. J Neurol，2006，253

（2）：237-241.

[50] LOPEZ-CANCIO E，JOVIN T G，COBO E，et al.

Endovascular treatment improves cognition after

stroke：a secondary analysis of REVASCAT trial[J].

Neurology，2017，88（3）：245-251.

[51] XU G D，DONG X L，NIU X L，et al. Cognitive

function and prognosis of multimodal neuroimageguided

thrombectomy on mild to moderate anterior

circulation infarction patients with broadened

therapeutic window：a prospective study[J]. Eur

Neurol，2017，78（5/6）：257-263.

[52] YANG Z，WANG H，EDWARDS D，et al.

Association of blood lipids，atherosclerosis and

statin use with dementia and cognitive impairment

after stroke：a systematic review and meta-analysis[J/

OL]. Ageing Res Rev，2020，57：100962[2020-02-

15]. https：//doi.org/10.1016/j.arr.2019.100962.

[53] VAN DER FLIER W M，SKOOG I，SCHNEIDER

J A，et al. Vascular cognitive impairment[J/OL]. Nat

Rev Dis Primers，2018，4：18003[2020-02-15].

https：//doi.org/10.1038/nrdp.2018.3.

[54] KIM J O，LEE S J，PYO J S. Effect of

acetylcholinesterase inhibitors on post-stroke

cognitive impairment and vascular dementia：a

meta-analysis[J/OL]. PLoS One，2020，15（2）：

e0227820[2020-02-15]. https：//doi.org/10.1371/

journal.pone.0227820.

[55] BARRETT K M，BROTT T G，BROWN R D Jr，et

al. Enhancing recovery after acute ischemic stroke

with donepezil as an adjuvant therapy to standard

medical care：results of a phase ⅡA clinical trial[J].

J Stroke Cerebrovasc Dis，2011，20（3）：177-182.

[56] BIRKS J，CRAIG D. Galantamine for vascular

cognitive impairment[J/OL]. Cochrane Database

Syst Rev，2006，4：CD004746[2020-02-15].

https：//doi.org/10.1002/14651858.CD004746.pub2.

[57] MCSHANE R，WESTBY M J，ROBERTS E，et al.

Memantine for dementia[J/OL]. Cochrane Database

Syst Rev，2019，3（3）：CD003154[2020-02-15].

https：//doi.org/10.1002/14651858.CD003154.pub6.

[58] BERTHIER M L，GREEN C，LARA J P，et al.

Memantine and constraint-induced aphasia therapy

in chronic poststroke aphasia[J]. Ann Neurol，2009，

65（5）：577-585.

[59] SYED Y Y. Sodium oligomannate：first approval[J].

Drugs，2020，80（4）：441-444.

[60] WANG T，KUANG W H，CHEN W，et al. A phase

II randomized trial of sodium oligomannate in

Alzheimer's dementia[J]. Alzheimers Res Ther，2020，

12（1）：110.

[61] JIA J P，WEI C B，LIANG J H，et al. The effects

of DL-3-n-butylphthalide in patients with vascular

cognitive impairment without dementia caused

by subcortical ischemic small vessel disease：a

multicentre，randomized，double-blind，placebocontrolled

trial[J]. Alzheimers Dement，2016，12（2）：

89-99.

[62] KANDIAH N，ONG P A，YUDA T，et al. Treatment

of dementia and mild cognitive impairment with or

without cerebrovascular disease：expert consensus

on the use of Ginkgo biloba extract，EGb761®[J].

CNS Neurosci Ther，2019，25（2）：288-298.

[63] CUI S H，CHEN N，YANG M，et al. Cerebrolysin

for vascular dementia[J/OL]. Cochrane Database

Syst Rev，2019，2019（11）：CD008900[2020-02-15].

https：//doi.org/10.1002/14651858.CD008900.pub3.

[64] GUEKHT A，SKOOG I，EDMUNDSON S，et al.

ARTEMIDA Trial（A Randomized Trial of Efficacy，

12 Months International Double-Blind Actovegin）：

a randomized controlled trial to assess the efficacy

of actovegin in poststroke cognitive impairment[J].

Stroke，2017，48（5）：1262-1270.

[65] WINBLAD B，FIORAVANTI M，DOLEZAL T，et

al. Therapeutic use of nicergoline[J]. Clin Drug

Investig，2008，28（9）：533-552.

[66] LÓPEZ-ARRIETA J M，BIRKS J. Nimodipine

for primary degenerative，mixed and vascular

dementia[J/OL]. Cochrane Database Syst Rev，

2002，3：CD000147[2020-02-15]. https：//doi.

org/10.1002/14651858.CD000147.

[67] 张微微，李小刚，王默力，等. 奥拉西坦治疗卒中后

认知功能障碍的有效性及安全性[J]. 中华神经科杂

志，2013，46（7）：489-493.

[68] FIORAVANTI M，YANAGI M.

Cytidinediphosphocholine（CDP-choline）for

cognitive and behavioural disturbances

associated with chronic cerebral disorders in

the elderly[J/OL]. Cochrane Database Syst Rev，

2005，2：CD000269[2020-02-15]. https：//doi.

org/10.1002/14651858.CD000269.pub2.

[69] SHA M C，CALLAHAN C M. The efficacy of

pentoxifylline in the treatment of vascular dementia：

a systematic review[J]. Alzheimer Dis Assoc Disord，

2003，17（1）：46-54.

[70] 付胜楠，何敏超，倪穗琴. 养血清脑颗粒治疗血管性

认知功能障碍的Meta分析[J]. 临床合理用药杂志，

2018，11（25）：24-26.

[71] 王旭生，刘伟，张萍，等. 消栓肠溶胶囊改善慢性脑

缺血患者脑循环及认知功能的临床研究[J]. 湖北中

医药大学学报，2020，22（2）：37-40.

[72] CHAN E S，BAUTISTA D T，ZHU Y，et al.

Traditional Chinese herbal medicine for vascular

dementia[J/OL]. Cochrane Database Syst Rev，

2018，12（12）：CD010284[2020-02-15]. https：//doi.

org/10.1002/14651858.CD010284.pub2.

[73] DE MAN-VAN GINKEL J M，GOOSKENS F，

SCHUURMANS M J，et al. A systematic review of

therapeutic interventions for poststroke depression

and the role of nurses[J]. J Clin Nurs，2010，19

（23/24）：3274-3290.

[74] MITCHELL P H，VEITH R C，BECKER K J，et

al. Brief psychosocial-behavioral intervention

with antidepressant reduces poststroke depression

significantly more than usual care with antidepressant：

living well with stroke：randomized，controlled

trial[J]. Stroke，2009，40（9）：3073-3078.

[75] SAVASKAN E，MUELLER H，HOERR R，et al.

Treatment effects of Ginkgo biloba extract EGb 761®

on the spectrum of behavioral and psychological

symptoms of dementia：meta-analysis of randomized

controlled trials[J]. Int Psychogeriatr，2018，30（3）：

285-293.

[76] MERRIMAN N A，SEXTON E，MCCABE G，et

al. Addressing cognitive impairment following

stroke：systematic review and meta-analysis of nonrandomised

controlled studies of psychological

interventions[J/OL]. BMJ Open，2019，9（2）：

e024429[2020-02-15]. https：//doi.org/10.1136/

bmjopen-2018-024429.

[77] TANG Y，XING Y，ZHU Z D，et al. The effects of

7-week cognitive training in patients with vascular

cognitive impairment，no dementia（the Cog-

VACCINE study）：a randomized controlled trial[J].

Alzheimers Dement，2019，15（5）：605-614.

[78] YEH T T，CHANG K C，WU C Y. The active

ingredient of cognitive restoration：a multicenter

randomized controlled trial of sequential

combination of aerobic exercise and computer-based

cognitive training in stroke survivors with cognitive

decline[J]. Arch Phys Med Rehabil，2019，100（5）：

821-827.

[79] FENG X F，HUANG L H，WANG Z W，et al.

Efficacy of remote limb ischemic conditioning on

poststroke cognitive impairment[J]. J Integr Neurosci，

2019，18（4）：377-385.

[80] WANG S H，YANG H L，ZHANG J，et al.

Efficacy and safety assessment of acupuncture and

nimodipine to treat mild cognitive impairment after

cerebral infarction：a randomized controlled trial[J].

BMC Complement Altern Med，2016，16（1）：361.

[81] BEGEMANN M J，BRAND B A，CURCIC-BLAKE

B，et al. Efficacy of non-invasive brain stimulation

on cognitive functioning in brain disorders：a metaanalysis[

J]. Psychol Med，2020，50（15）：2465-

2486.

[82] CANTONE M，LANZA G，FISICARO F，et al.

Evaluation and treatment of vascular cognitive

impairment by transcranial magnetic stimulation[J/

OL]. Neural Plast，2020，2020：8820881[2020-02-

15]. https：//doi.org/10.1155/2020/8820881.